Holen Sie sich die Stockscreener-App
29.71
0.88%
-0.263
Schlusskurs vom Vortag:
$29.97
Offen:
$29.71
24-Stunden-Volumen:
100
Relative Volume:
0.15
Marktkapitalisierung:
$N/A
Einnahmen:
$3.38M
Nettoeinkommen (Verlust:
$-8.29M
KGV:
-135.05
EPS:
-0.22
Netto-Cashflow:
$-1.99M
1W Leistung:
+1.65%
1M Leistung:
+3.28%
6M Leistung:
+1,588%
1J Leistung:
+1,588%
1-Tages-Spanne:
$29.71
$29.71
1-Wochen-Bereich:
$29.34
$30.28
52-Wochen-Spanne:
$1.58
$30.39
Second Sight Medical Products, Stock (EYES) Company Profile
Firmenname
Second Sight Medical Products,
Sektor
Branche
Telefon
818-833-5000
Adresse
12744 San Fernando Road, Suite 400, Sylmar
Compare EYES vs VOO, IVV, SPY, VTI, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EYES
Second Sight Medical Products,
|
29.71 | 0 | 3.38M | -8.29M | -1.99M | -0.22 |
VOO
Vanguard S P 500 Etf
|
710.35 | 1.05T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
776.20 | 890.68B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
772.80 | 816.18B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
378.57 | 697.24B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
736.11 | 492.31B | 0 | 0 | 0 | 0.00 |
Second Sight Medical Products, Stock (EYES) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-12-13 | Eingeleitet | Dougherty & Company | Buy |
| 2015-07-06 | Eingeleitet | H.C. Wainwright | Buy |
Second Sight Medical Products, Aktie (EYES) Neueste Nachrichten
Palantir's Growth Story Gets a Goldman Boost: ETFs to Consider - The Globe and Mail
Palantir's Growth Story Gets a Goldman Boost: ETFs to Consider - Zacks Investment Research
Best Performing ETFs: Top Returns at a Glance - TradingKey
Second Sight Medical Products Inc (VANIW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Second Sight Medical Products Inc (VANIW) Peer Comparison – Compare with Others - Value Research
Second Sight Medical Products Inc. Warrants (EYESW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Second Sight Medical Products Inc. Warrants (EYESW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Second Sight Medical Products Inc. Warrants (EYESW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Second Sight Medical Products Inc. (EYES) Peer Comparison – Compare with Others - Value Research
Second Sight Medical Products Inc (VANIW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Second Sight Medical Products Inc (VANIW) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
ETF Edge on thematic and active ETFs outside of AI and trends to watch - CNBC
Palantir's post-earnings rally puts PLTR-heavy ETFs in focus (PLTR:NASDAQ) - Seeking Alpha
The corgi-inspired ETF provider that wants to disrupt BlackRock - Financial Times
EU Clears PRIMA Retinal Chip for Commercial Sale After AMD Patient Reads 300-Page Novel - The Eastern Herald
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream - GlobeNewswire Inc.
ClearOne skyrockets from neurotech pivot, merger with Cortigent - Mugglehead Investment Magazine
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - markets.businessinsider.com
Vivani Medical allows Novo Nordisk to evaluate NPM-139 - scanx.trade
ClearOne Merging With Cortigent - Pulse 2.0
Vivani to sell neurotech subsidiary Cortigent to ClearOne - MassDevice
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical - Business Wire
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker - GlobeNewswire
Vivani Medical appoints August Moretti to board as Dr. Dean Baker retires - scanx.trade
Looking for Exposure to Palantir Stock (PLTR) at New Lows? These 2 ETFs Offer Over 35% Upside - TipRanks
Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - markets.businessinsider.com
European Union Retinal Implant Electrode ArraysMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Corgi Quantum Computing ETF (CQTM) stock price, news, quote and history - Yahoo Finance Australia
World Auditory Brainstem ImplantsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Visual Prosthesis Market Size, Share, Growth, Forecast, 2034 - Straits Research
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 - markets.businessinsider.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - markets.businessinsider.com
Corgi Data & Surveillance ETF (EYES) Holdings - Yahoo! Finance Canada
EYES ETF Price and Chart — CBOE:EYES - TradingView
Corgi Funds Launches Record 34 ETFs - ETF Database
Corgi Funds Launches Record 34 ETFs - ETF Trends
Corgi Launches 34 ETFs & Raises $160M in a Single Day - ETF.com
/C O R R E C T I O N -- Corgi Funds/ - PR Newswire
EYES ETF Profile: Dividends, Returns (CBOE:EYES) - tradingview.com
Medical Bionic Implant and Artificial Organs Price in the European UnionMarket Insights - IndexBox
Stock List: Research Stocks from Around the World - GuruFocus
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire
Single semaglutide implant showed >20% weight loss for a year - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
Promising Six-Year Early Feasibility Study Results Released for the Orion System - Medical Product Outsourcing
Electroceuticals Market Size, Share & Growth Report, 2034 - Market Data Forecast
'Bionic Eye' Helps Man See After Decade of Impaired VisionABC News - ABC News - Breaking News, Latest News and Videos
Don’t Let Elon Musk Implant a Device in Your Skull - Home ❧ Current Affairs
Finanzdaten der Second Sight Medical Products,-Aktie (EYES)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):